LBG
CELG

Lloyds Banking Group’s Celgene Corp CELG Stock Holding History

Lloyds Banking Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,566
Closed -$717K – 512
2014
Q3 		$717K Buy
7,566
+3,540
+88% +$319K 0.2% 129
2014
Q2 		$345K Sell
4,026
-443,790
-99% -$33.7M 0.08% 216
2014
Q1 		$31.3M Sell
447,816
-3,656
-0.8% -$290K 0.28% 104
2013
Q4 		$38.1M Buy
451,472
+3,348
+0.7% +$265K 0.34% 74
2013
Q3 		$34.5M Buy
448,124
+74,576
+20% +$5.23M 0.35% 75
2013
Q2 		$21.8M Buy
+373,548
New +$22.5M 0.23% 112

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lloyds Banking Group's CELG Position: Q4 2014 in Review

Lloyds Banking Group sold out of Celgene Corp (CELG) in Q4 2014, closing a stake of 7,566 shares — an estimated $717K sold.

Lloyds Banking Group first reported a position in CELG in Q2 2013 and held it in 6 quarters. The position peaked at $38.1M in Q4 2013. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Lloyds Banking Group reported no remaining Celgene Corp position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 7,566 Celgene Corp shares in Q4 2014, an estimated $717K.
  • Lloyds Banking Group first reported a position in Celgene Corp in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Celgene Corp position peaked at $38.1M in Q4 2013.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.